Interaction between tramadol and selective serotonin reuptake inhibitors: are doctors aware of potential risks in their prescription practice?

Spies, Petra E; Pot, J L W Hans; Willems, Roel P J; Bos, Jacqueline M; Kramers, Cornelis

Spies, Petra E; Pot, J L W Hans; Willems, Roel P J; Bos, Jacqueline M; Kramers, Cornelis.

Afiliação

Spies PE; Department of Geriatric Medicine, Gelre Hospitals, Apeldoorn, The Netherlands.
Pot JLWH; Meander Medical Centre, Amersfoort, The Netherlands.
Willems RPJ; Amphia Hospital, Breda, The Netherlands.
Bos JM; Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.
Kramers C; Canisius-Wilhelmina Hospital, Nijmegen, The Netherlands.

Eur J Hosp Pharm ; 24(2): 124-127, 2017 Mar.

Article em En | MEDLINE | ID: mdl-31156918

Palavras-chave

antidepressant; awareness; opioid; pharmacovigilance; serotonin syndrome

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Qualitative_research / Risk_factors_studies Idioma: En Revista: Eur J Hosp Pharm Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Holanda

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google